Molecular signature of cardiomyocyte clusters derived from human embryonic stem cells. 2008

Jane Synnergren, and Karolina Akesson, and Kerstin Dahlenborg, and Hilmar Vidarsson, and Caroline Améen, and Daniella Steel, and Anders Lindahl, and Björn Olsson, and Peter Sartipy
School of Humanities and Informatics, University of Skövde, P.O. Box 408, SE-541 28 Skövde, Sweden. jane.synnergren@his.se

Human embryonic stem cells (hESCs) can differentiate in vitro into spontaneously contracting cardiomyocytes (CMs). These cells may prove extremely useful for various applications in basic research, drug discovery, and regenerative medicine. To fully use the potential of the cells, they need to be extensively characterized, and the regulatory mechanisms that control hESC differentiation toward the cardiac lineage need to be better defined. In this study, we used microarrays to analyze, for the first time, the global gene expression profile of isolated hESC-derived CM clusters. By comparing the clusters with undifferentiated hESCs and using stringent selection criteria, we identified 530 upregulated and 40 downregulated genes in the contracting clusters. To further characterize the family of upregulated genes in the hESC-derived CM clusters, the genes were classified according to their Gene Ontology annotation. The results indicate that the hESC-derived CM clusters display high similarities, on a molecular level, to human heart tissue. Moreover, using the family of upregulated genes, we created protein interaction maps that revealed topological characteristics. We also searched for cellular pathways among the upregulated genes in the hESC-derived CM clusters and identified eight significantly upregulated pathways. Real-time quantitative polymerase chain reaction and immunohistochemical analysis confirmed the expression of a subset of the genes identified by the microarrays. Taken together, the results presented here provide a molecular signature of hESC-derived CM clusters and further our understanding of the biological processes that are active in these cells.

UI MeSH Term Description Entries
D008957 Models, Genetic Theoretical representations that simulate the behavior or activity of genetic processes or phenomena. They include the use of mathematical equations, computers, and other electronic equipment. Genetic Models,Genetic Model,Model, Genetic
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015536 Down-Regulation A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Down-Regulation,Down-Regulation (Physiology),Downregulation,Down Regulation,Down-Regulation, Receptor
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation
D046149 Embryo Culture Techniques The technique of maintaining or growing mammalian EMBRYOS in vitro. This method offers an opportunity to observe EMBRYONIC DEVELOPMENT; METABOLISM; and susceptibility to TERATOGENS. Blastocyst Culture Techniques,Blastocyst Culture Technique,Culture Technique, Blastocyst,Culture Technique, Embryo,Culture Techniques, Blastocyst,Culture Techniques, Embryo,Embryo Culture Technique
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Jane Synnergren, and Karolina Akesson, and Kerstin Dahlenborg, and Hilmar Vidarsson, and Caroline Améen, and Daniella Steel, and Anders Lindahl, and Björn Olsson, and Peter Sartipy
October 2010, Journal of molecular cell biology,
Jane Synnergren, and Karolina Akesson, and Kerstin Dahlenborg, and Hilmar Vidarsson, and Caroline Améen, and Daniella Steel, and Anders Lindahl, and Björn Olsson, and Peter Sartipy
May 2019, Stem cells and development,
Jane Synnergren, and Karolina Akesson, and Kerstin Dahlenborg, and Hilmar Vidarsson, and Caroline Améen, and Daniella Steel, and Anders Lindahl, and Björn Olsson, and Peter Sartipy
January 2018, Methods in molecular biology (Clifton, N.J.),
Jane Synnergren, and Karolina Akesson, and Kerstin Dahlenborg, and Hilmar Vidarsson, and Caroline Améen, and Daniella Steel, and Anders Lindahl, and Björn Olsson, and Peter Sartipy
August 2019, Nature biotechnology,
Jane Synnergren, and Karolina Akesson, and Kerstin Dahlenborg, and Hilmar Vidarsson, and Caroline Améen, and Daniella Steel, and Anders Lindahl, and Björn Olsson, and Peter Sartipy
November 2008, Experimental hematology,
Jane Synnergren, and Karolina Akesson, and Kerstin Dahlenborg, and Hilmar Vidarsson, and Caroline Améen, and Daniella Steel, and Anders Lindahl, and Björn Olsson, and Peter Sartipy
June 2005, Development, growth & differentiation,
Jane Synnergren, and Karolina Akesson, and Kerstin Dahlenborg, and Hilmar Vidarsson, and Caroline Améen, and Daniella Steel, and Anders Lindahl, and Björn Olsson, and Peter Sartipy
May 2010, Science China. Life sciences,
Jane Synnergren, and Karolina Akesson, and Kerstin Dahlenborg, and Hilmar Vidarsson, and Caroline Améen, and Daniella Steel, and Anders Lindahl, and Björn Olsson, and Peter Sartipy
August 2015, Stem cells (Dayton, Ohio),
Jane Synnergren, and Karolina Akesson, and Kerstin Dahlenborg, and Hilmar Vidarsson, and Caroline Améen, and Daniella Steel, and Anders Lindahl, and Björn Olsson, and Peter Sartipy
June 2010, Stem cells and development,
Jane Synnergren, and Karolina Akesson, and Kerstin Dahlenborg, and Hilmar Vidarsson, and Caroline Améen, and Daniella Steel, and Anders Lindahl, and Björn Olsson, and Peter Sartipy
January 2008, Drug discovery today. Technologies,
Copied contents to your clipboard!